52 related articles for article (PubMed ID: 15273267)
21. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
22. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of hepatitis C incidence in Australian prisoners.
Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
[TBL] [Abstract][Full Text] [Related]
26. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
[TBL] [Abstract][Full Text] [Related]
27. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.
Dolan KA; Shearer J; MacDonald M; Mattick RP; Hall W; Wodak AD
Drug Alcohol Depend; 2003 Oct; 72(1):59-65. PubMed ID: 14563543
[TBL] [Abstract][Full Text] [Related]
28. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A
Int J Epidemiol; 2003 Oct; 32(5):717-24. PubMed ID: 14559738
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons.
O'Sullivan BG; Levy MH; Dolan KA; Post JJ; Barton SG; Dwyer DE; Kaldor JM; Grulich AE
Med J Aust; 2003 Jun; 178(11):546-9. PubMed ID: 12765501
[TBL] [Abstract][Full Text] [Related]
30. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route.
Post JJ; Dolan KA; Whybin LR; Carter IW; Haber PS; Lloyd AR
Med J Aust; 2001 Feb; 174(4):183-4. PubMed ID: 11270759
[TBL] [Abstract][Full Text] [Related]
31. Transmission of hepatitis C within Australian prisons.
Haber PS; Parsons SJ; Harper SE; White PA; Rawlinson WD; Lloyd AR
Med J Aust; 1999 Jul; 171(1):31-3. PubMed ID: 10451669
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment.
Best D; Noble A; Finch E; Gossop M; Sidwell C; Strang J
BMJ; 1999 Jul; 319(7205):290-1. PubMed ID: 10426739
[No Abstract] [Full Text] [Related]
33. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges.
Ogilvie EL; Veit F; Crofts N; Thompson SC
J Adolesc Health; 1999 Jul; 25(1):46-51. PubMed ID: 10418885
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
[TBL] [Abstract][Full Text] [Related]
35. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.
Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA;
J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267
[TBL] [Abstract][Full Text] [Related]
38. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
39. Enhancing assessment and treatment of hepatitis C in the custodial setting.
Post JJ; Arain A; Lloyd AR
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
[TBL] [Abstract][Full Text] [Related]
40. A framework for management of hepatitis C in prisons.
Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
